Ampio Pharmaceuticals Announces Agreement to Acquire Key Drug Delivery Technology
Published: Tuesday, December 06, 2011 Last Updated: Tuesday, December 06, 2011
The company, that discovers and develops new uses for previously approved drugs and new molecular entities ("NMEs"), has acquired certain rights relating to a patented orally disintegrating tablet (ODT) drug delivery technology that can be used worldwide to elevate the market acceptance of Ampio's Zertane™ product for premature ejaculation.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.